Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Marimed Inc (OP:MRMD)

0.1042 +0.0002 (+0.19%)
Streaming Delayed Price Updated: 3:35 PM EDT, Mar 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Marimed Inc

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Bearish Sentiment Across The Cannabis Space - Check Full Movers For March 13, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bullish Sentiment Across The Cannabis Space - Check Full Movers For March 11, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For March 10, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Exploring MariMed's Earnings Expectations
Via Benzinga
This Week In Cannabis: Snoop's Beverage Empire, Earnings, M&A, International News And More
This week's cannabis news: Snoop Dogg expands his cannabis empire, Planet 13 recovers millions, Glass House locks in $50M & top earnings drop. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Co. MariMed Finalizes $11M Deal To Acquire First State Compassion
MariMed acquires First State Compassion, expanding its cannabis footprint in Delaware ahead of adult-use sales. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For February 17, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Valuations Reflect No Expectation Of Federal Reform: Study
Viridian Capital's latest report shows cannabis stocks pricing in no rescheduling or 280E relief, leaving MSOs stuck in valuation limbo. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For December 25, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From December 24, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat?
For investors, MariMed represents a fundamentally strong outlier, but industry-wide challenges remain a drag on stock performance. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
MariMed's Q3 Revenue Slightly Up YoY As Net Loss Improves, Revises Guidance
Via Benzinga
Cannabis Company Launches Veterans Aid: $5K Grants For Housing Relief In Key Markets
Via Benzinga
Topics Cannabis
Exposures Cannabis
Edibles Surge In The Heartland: MariMed's Play For Missouri And Illinois Cannabis Dominance
MariMed, a multi-state cannabis operator, is doubling down on its growth strategy by launching manufacturing operations in Missouri. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Can MariMed's $7.7M Illinois Cannabis Expansion Turn The Tide In A $496M Market?
Despite overall market stagnation, MariMed aims to boost growth through capacity expansion, including a new 14,000 sq ft cultivation site. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For October 24, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For October 22, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For October 22, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For October 18, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From October 16, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bullish Monday For Marijuana Stocks - Body and Mind, Global Compliance Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Almost Every Major Cannabis Company Could See Positive Cash Flow If 280E Is Removed In 2025
Removing 280E in 2025 could drastically improve cash flow for cannabis companies. See how major MSOs like Green Thumb, Trulieve, and Cresco.. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
EXCLUSIVE: Emotional Connection With Consumers Is Secret Sauce For Any Brand To Prosper, It's Same With Cannabis, Experts Say
At the Benzinga Cannabis Capital Conference in Chicago, one panel addresses how cannabis products meet consumers' needs. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Chart Of The Week: Consensus 2024 EBITDA Estimates Are Still Up 8.4% Despite Downward Revisions
The chart shows the percentage change in consensus 2024 EBITDA estimates between the end of 2023 and now. The orange bars represent the portion of EBITDA % change attributable to changes in EBITDA... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For October 11, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For October 7, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
These Two Marijuana Giants Will Soon Report Earnings, Hear From CEOs At Benzinga Cannabis Conference
Cannabis company Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) will report its financial and operating results for the third quarter that ended Sept. 30, 2024 after market close on Nov. 6, 2024.... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bullish Sentiment Across The Cannabis Space - Check Full Movers For September 23, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Don't Let Hidden Debt Fool You: How Cannabis Investors Can Tell If They Are Safe
Viridian Capital Advisors provides cannabis investors with a more comprehensive EV calculation compared to traditional methods. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For September 20, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.